Daratumumab monotherapy for refractory lupus nephritis

Treatment-refractory lupus nephritis (LN) has a high risk of a poor outcome and is often life-threatening. Here we report a case series of six patients (one male and five females) with a median age of 41.3 years (range, 20–61 years) with refractory LN who received renal biopsies and were subsequentl...

Descripción completa

Detalles Bibliográficos
Autores principales: Roccatello, Dario, Fenoglio, Roberta, Caniggia, Ilaria, Kamgaing, Joelle, Naretto, Carla, Cecchi, Irene, Rubini, Elena, Rossi, Daniela, De Simone, Emanuele, Del Vecchio, Giulio, Cozzi, Martina, Sciascia, Savino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427415/
https://www.ncbi.nlm.nih.gov/pubmed/37563241
http://dx.doi.org/10.1038/s41591-023-02479-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427415/
https://www.ncbi.nlm.nih.gov/pubmed/37563241
http://dx.doi.org/10.1038/s41591-023-02479-1

Ejemplares similares